BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 12428682)

  • 1. Reduction in the extent of atherosclerosis in apolipoprotein E-deficient mice induced by electroporation-mediated transfer of the human plasma platelet-activating factor acetylhydrolase gene into skeletal muscle.
    Hase M; Tanaka M; Yokota M; Yamada Y
    Prostaglandins Other Lipid Mediat; 2002 Sep; 70(1-2):107-18. PubMed ID: 12428682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice.
    Quarck R; De Geest B; Stengel D; Mertens A; Lox M; Theilmeier G; Michiels C; Raes M; Bult H; Collen D; Van Veldhoven P; Ninio E; Holvoet P
    Circulation; 2001 May; 103(20):2495-500. PubMed ID: 11369691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis.
    De Geest B; Stengel D; Landeloos M; Lox M; Le Gat L; Collen D; Holvoet P; Ninio E
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E68-75. PubMed ID: 11031226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice.
    Theilmeier G; De Geest B; Van Veldhoven PP; Stengel D; Michiels C; Lox M; Landeloos M; Chapman MJ; Ninio E; Collen D; Himpens B; Holvoet P
    FASEB J; 2000 Oct; 14(13):2032-9. PubMed ID: 11023987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasma platelet-activating factor acetylhydrolase binds to all the murine lipoproteins, conferring protection against oxidative stress.
    Noto H; Hara M; Karasawa K; Iso-O N; Satoh H; Togo M; Hashimoto Y; Yamada Y; Kosaka T; Kawamura M; Kimura S; Tsukamoto K
    Arterioscler Thromb Vasc Biol; 2003 May; 23(5):829-35. PubMed ID: 12649088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered activities of anti-atherogenic enzymes LCAT, paraoxonase, and platelet-activating factor acetylhydrolase in atherosclerosis-susceptible mice.
    Forte TM; Subbanagounder G; Berliner JA; Blanche PJ; Clermont AO; Jia Z; Oda MN; Krauss RM; Bielicki JK
    J Lipid Res; 2002 Mar; 43(3):477-85. PubMed ID: 11893784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations between plasma platelet-activating factor acetylhydrolase (PAF-AH) activity and PAF-AH genotype, age, and atherosclerosis in a Japanese population.
    Yamada Y; Yoshida H; Ichihara S; Imaizumi T; Satoh K; Yokota M
    Atherosclerosis; 2000 May; 150(1):209-16. PubMed ID: 10781653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response.
    Memon RA; Fuller J; Moser AH; Feingold KR; Grunfeld C
    Am J Physiol; 1999 Jul; 277(1):R94-103. PubMed ID: 10409262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All ApoB-containing lipoproteins induce monocyte chemotaxis and adhesion when minimally modified. Modulation of lipoprotein bioactivity by platelet-activating factor acetylhydrolase.
    Lee C; Sigari F; Segrado T; Hörkkö S; Hama S; Subbaiah PV; Miwa M; Navab M; Witztum JL; Reaven PD
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1437-46. PubMed ID: 10364074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein E-containing HDL-associated platelet-activating factor acetylhydrolase activities and malondialdehyde concentrations in patients with PCOS.
    Fan P; Liu H; Wang Y; Zhang F; Bai H
    Reprod Biomed Online; 2012 Feb; 24(2):197-205. PubMed ID: 22197603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice.
    Singh U; Zhong S; Xiong M; Li TB; Sniderman A; Teng BB
    Clin Sci (Lond); 2004 Apr; 106(4):421-32. PubMed ID: 14717654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial purification and localization of platelet-activating factor acetylhydrolase from bovine seminal plasma.
    Hough SR; Parks JE
    J Androl; 1997; 18(5):540-8. PubMed ID: 9349753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mouse plasma PAF acetylhydrolase: I. Characterization and properties.
    Tsaoussis V; Vakirtzi-Lemonias C
    J Lipid Mediat Cell Signal; 1994 May; 9(3):301-15. PubMed ID: 7921789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative sensitivities of plasma lecithin:cholesterol acyltransferase, platelet-activating factor acetylhydrolase, and paraoxonase to in vitro gas-phase cigarette smoke exposure.
    Bielicki JK; Knoff LJ; Tribble DL; Forte TM
    Atherosclerosis; 2001 Mar; 155(1):71-8. PubMed ID: 11223428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.
    Karabina SA; Elisaf M; Bairaktari E; Tzallas C; Siamopoulos KC; Tselepis AD
    Eur J Clin Invest; 1997 Jul; 27(7):595-602. PubMed ID: 9263748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hormonal regulation of platelet-activating factor-acetylhydrolase in the rat.
    Yasuda K; Johnston JM
    Endocrinology; 1992 Feb; 130(2):708-16. PubMed ID: 1733719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular source(s) of platelet-activating-factor acetylhydrolase activity in plasma.
    Asano K; Okamoto S; Fukunaga K; Shiomi T; Mori T; Iwata M; Ikeda Y; Yamaguchi K
    Biochem Biophys Res Commun; 1999 Aug; 261(2):511-4. PubMed ID: 10425216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB.
    Tsimihodimos V; Karabina SA; Tambaki AP; Bairaktari E; Goudevenos JA; Chapman MJ; Elisaf M; Tselepis AD
    Arterioscler Thromb Vasc Biol; 2002 Feb; 22(2):306-11. PubMed ID: 11834533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hypolipidemic drugs on lipoprotein-associated platelet activating factor acetylhydrolase. Implication for atherosclerosis.
    Eisaf M; Tselepis AD
    Biochem Pharmacol; 2003 Dec; 66(11):2069-73. PubMed ID: 14609731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.